Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, Dalton Venture, Zhidao Capital, Shanghai Guofang Private Equity Fund Management Company, Suzhou Zhongxin Innovation Investment Management — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Pairui Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Pairui Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pairui Biotechnology
Developer of bio-based materials technologies and cell technologies designed for medical and healthcare technology development. The company produces bio-based materials and develops cell technology, providing medical industry users with technology and material solutions.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Pairui Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pairui Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pairui Biotechnology in its N-PORT filings yet. We sweep new filings monthly.